Kite Pharma Announces Pricing of Follow-On Offering
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Kite Pharma (KITE) Prices 3.49M Common Follow-On Offering at $54/Share
December 11, 2014 9:11 AM ESTKite Pharma (NASDAQ: KITE) announced the pricing of its follow-on public offering of 3,485,000 shares of its common stock, an increase of 485,000 shares from the number of shares originally offered, at a price to the public of $54 per share. In addition, the underwriters have... More
